F919-0255 Screening compound: 3,4-dimethoxy-N-[5-(4-methylpiperazine-1-carbonyl)-2-(piperazin-1-yl)phenyl]benzene-1-sulfonamide

F919-0255 Screening compound: 3,4-dimethoxy-N-[5-(4-methylpiperazine-1-carbonyl)-2-(piperazin-1-yl)phenyl]benzene-1-sulfonamide
F919-0255 Screening compound: 3,4-dimethoxy-N-[5-(4-methylpiperazine-1-carbonyl)-2-(piperazin-1-yl)phenyl]benzene-1-sulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F919-0255
3,4-dimethoxy-N-[5-(4-methylpiperazine-1-carbonyl)-2-(piperazin-1-yl)phenyl]benzene-1-sulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F919-0255

Molecular Formula

C24H33N5O5S (C24 H33 N5 O5 S)

Compound Name

3,4-dimethoxy-N-[5-(4-methylpiperazine-1-carbonyl)-2-(piperazin-1-yl)phenyl]benzene-1-sulfonamide

IUPAC name

34-dimethoxy-N-[5-(4-methylpiperazine-1-carbonyl)-2-(piperazin-1-yl)phenyl]benzene-1-sulfonamide

SMILES

CN(CC1)CCN1C(c(cc1)cc(NS(c(cc2)cc(OC)c2OC)(=O)=O)c1N1CCNCC1)=O

InChI

InChI=1S/C24H33N5O5S/c1-27-12-14-29(15-13-27)24(30)18-4-6-21(28-10-8-25-9-11-28)20(16-18)26-35(31,32)19-5-7-22(33-2)23(17-19)34-3/h4-7,16-17,25-26H,8-15H2,1-3H3

InChI Key

WBRNIRYQLHVUMN-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14971719

Chemical and Physical Properties

Saltdata

CF3COOH

Molecular Weight

503.62

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

0.581

Distribution Coefficient, logD

-0.619

Water Solubility, LogSw

-2.50

Polar Surface Area

90.688

Acid Dissociation Constant (pKa)

7.81

Base Dissociation Constant (pKb)

8.71

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

45.80

F919-0255 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Antimitotic Tubulin Library (17355 compounds)

Lipid Metabolism Library (9174 compounds)

Protein-Protein Interaction Library (218420 compounds)

Chemokine Receptor-Targeted Library (18382 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cardiovascular
  • Metabolic
  • Immune system
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators
  • Receptor's ligands

References: we are preparing a list of scientific research reports with F919-0255 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F919-0255?
Check Price and Availability of F919-0255, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F919-0255 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F919-0255
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F919-0255
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F919-0255 available by request